Judi O'shaughnessy

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Single-molecule validation and optimised protocols for the use of secondary nanobodies in multiplexed immunoassays.

Single-molecule validation and optimised protocols for the use of secondary nanobodies in multiplexed immunoassays.

Journal: Journal of microscopy

Published: September 12, 2025

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.

Journal: Annals of neurology

Published: March 25, 2025

Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis.

Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis.

Journal: Brain communications

Published: November 07, 2024

Characterisation and comparison of Mycoplasma bovis strain types from Irish and Scottish bovine isolates in a global context.

Characterisation and comparison of Mycoplasma bovis strain types from Irish and Scottish bovine isolates in a global context.

Journal: Veterinary microbiology

Published: June 27, 2024

Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis.

Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis.

Journal: bioRxiv : the preprint server for biology

Published: June 10, 2024

Clinicopathological analysis of NEK1 variants in amyotrophic lateral sclerosis.

Clinicopathological analysis of NEK1 variants in amyotrophic lateral sclerosis.

Journal: Brain pathology (Zurich, Switzerland)

Published: April 02, 2024

RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS.

RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS.

Journal: Acta neuropathologica

Published: November 28, 2023

Two-color coincidence single-molecule pulldown for the specific detection of disease-associated protein aggregates.

Two-color coincidence single-molecule pulldown for the specific detection of disease-associated protein aggregates.

Journal: Science advances

Published: November 15, 2023

Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts.

Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts.

Journal: Brain : a journal of neurology

Published: March 26, 2023

pTDP-43 aggregates accumulate in non-central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical phenotypic data.

pTDP-43 aggregates accumulate in non-central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical phenotypic data.

Journal: The journal of pathology. Clinical research

Published: July 24, 2022

Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALS.

Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALS.

Journal: The Journal of pathology

Published: June 24, 2022

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis.

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis.

Journal: The Journal of pathology

Published: August 12, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026